Back to User profile » Dr Chellan Kumarasamy
Papers published by Dr Chellan Kumarasamy:
The Significance of miRNAs as a Prognostic Biomarker for Survival Outcome in T Cell – Acute Lymphoblastic Leukemia Patients: A Systematic Review and Meta-Analysis
Sabarimurugan S, Kumarasamy C, Royam Madhav M, Samiappan S, Jayaraj R
Cancer Management and Research 2020, 12:819-839
Published Date: 5 February 2020
Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy
Jayaraj R, Kumarasamy C, Sabarimurugan S, Samiappan S
Cancer Management and Research 2019, 11:3349-3350
Published Date: 18 April 2019
Meta-analysis of the prognostic role of HE4 expression in cancer patients: clinical insights into interpretation of clinical outcomes
Jayaraj R, Kumarasamy C
Cancer Management and Research 2019, 11:1791-1794
Published Date: 21 February 2019
Letter to the editor regarding the publication “Association between matrix-metalloproteinase polymorphisms and prostate cancer risk: a meta-analysis and systematic review”
Jayaraj R, Kumarasamy C
Cancer Management and Research 2019, 11:1067-1068
Published Date: 24 January 2019
Systematic review and meta-analysis of cancer studies evaluating diagnostic test accuracy and prognostic values: approaches to improve clinical interpretation of results
Jayaraj R, Kumarasamy C
Cancer Management and Research 2018, 10:4669-4670
Published Date: 16 October 2018
Letter to the editor “Prognostic value of microRNAs in colorectal cancer: a meta-analysis”
Jayaraj R, Kumarasamy C, Gothandam KM
Cancer Management and Research 2018, 10:3501-3503
Published Date: 13 September 2018